Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Normal Upper Extremity”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT00027989
What this trial is testing

Liposomal Doxorubicin and Gemcitabine in Treating Women With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Pharmatech Oncology
Testing effectiveness (Phase 2)Looking for participantsNCT06284590
What this trial is testing

Study of the Efficacy of Intratumoral L19IL2 or L19TNF or L19IL2/L19TNF, in Combination With Pembrolizumab, in Unresectable Melanoma Patients

Who this might be right for
Melanoma Stage IIIMelanoma Stage IV
Philogen S.p.A. 162
Not applicableStudy completedNCT03760926
What this trial is testing

A Trial of the May Health Device in Transvaginal Ablation of Ovarian Tissue Under ULTRAsound Visualization in Women With PCOS Infertility

Who this might be right for
Polycystic Ovary Syndrome
May Health 28
Testing effectiveness (Phase 2)Study completedNCT00156247
What this trial is testing

Acitretin and Etanercept in Psoriasis

Who this might be right for
Psoriasis
University of Medicine and Dentistry of New Jersey 10
Testing effectiveness (Phase 2)Study completedNCT04499950
What this trial is testing

Adaptive Nutrition and Exercise Weight Loss (A-NEW) Study

Who this might be right for
Breast CancerOverweight or Obesity
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 53
Testing effectiveness (Phase 2)UnknownNCT03815474
What this trial is testing

Anlotinib Hydrochloride Combined With Epirubicin and Ifosfamide for Soft Tissue Sarcoma Patients

Who this might be right for
Sarcoma, Soft Tissue
Liaoning Cancer Hospital & Institute 47
Large-scale testing (Phase 3)Study completedNCT01726933
What this trial is testing

LAS41008 in Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Almirall, S.A. 839
Not applicableActive Not RecruitingNCT05230550
What this trial is testing

Post-Marketing Surveillance (Special Use-results Surveillance on Long-term Use) With Sogroya®

Who this might be right for
Adult Growth Hormone Deficiency
Novo Nordisk A/S 200
Testing effectiveness (Phase 2)Looking for participantsNCT07602049
What this trial is testing

Cryoablation Plus Camrelizumab for Advanced Soft Tissue Sarcoma

Who this might be right for
Soft Tissue Sarcoma (STS)Osteosarcoma
Sun Yat-sen University 57
Large-scale testing (Phase 3)Study completedNCT00483782
What this trial is testing

Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Newly Diagnosed Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer

Who this might be right for
Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer
Medical Research Council 1,520
Testing effectiveness (Phase 2)UnknownNCT03390062
What this trial is testing

Apatinib in Recurrent or Recurrent High-grade Glioma

Who this might be right for
Glioma
West China Hospital 30
Testing effectiveness (Phase 2)UnknownNCT05885776
What this trial is testing

Preoperative Treatment of HR+/HER2+Breast Cancer With Pirotinib, Trastuzumab and AI Research

Who this might be right for
Breast Cancer
Tianjin Medical University Cancer Institute and Hospital 48
Testing effectiveness (Phase 2)Study completedNCT02847559
What this trial is testing

Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma

Who this might be right for
Anaplastic (Malignant) MeningiomaAtypical MeningiomaGrade II Meningioma+3 more
Northwestern University 20
Post-approval studies (Phase 4)Study completedNCT01926496
What this trial is testing

Risk of Squamous Cell Carcinoma on Skin Areas Treated With Ingenol Mebutate Gel, 0.015% and Imiquimod Cream, 5%

Who this might be right for
Actinic Keratosis (AK)
LEO Pharma 485
Not applicableUnknownNCT04987424
What this trial is testing

Prevalence of Lymphedema in Valle Del Cauca, Colombia.

Who this might be right for
Unilateral Breast Cancer
Grupo de investigación C.E.R 367
Testing effectiveness (Phase 2)Study completedNCT04256759
What this trial is testing

Dupilumab for the Treatment of Moderate to Severe Chronic Hepatic Pruritus

Who this might be right for
Pruritus
Mayo Clinic 9
Testing effectiveness (Phase 2)WithdrawnNCT02876003
What this trial is testing

Efficacy and Safety of G-202 in PSMA-Positive Glioblastoma

Who this might be right for
Glioblastoma
GenSpera, Inc.
Very early researchNot Yet RecruitingNCT06621303
What this trial is testing

Autonomous Regulatory Monocytes (OPM Cells) for the Treatment of Diabetic Foot in a Single-arm Open-label Clinical Study

Who this might be right for
Diabetic Foot Ulcer
Shanghai East Hospital 10
Testing effectiveness (Phase 2)Active Not RecruitingNCT07266090
What this trial is testing

Evaluate the Safety,Tolerability,Pharmacokinetics and Pharmacodynamics of Cenerimod in Adult Chinese Participants With Moderate-to-severe Systemic Lupus Erythematosus (SLE)

Who this might be right for
SLE - Systemic Lupus Erythematosus
Viatris Pharmaceuticals Co., Ltd. 15
Not applicableNot Yet RecruitingNCT07425379
What this trial is testing

Prehabilitation in Breast Cancer Surgery

Who this might be right for
Breast Cancer (Early Breast Cancer)Postoperative Shoulder DysfunctionLymphedema Arm+1 more
Bakirkoy Dr. Sadi Konuk Research and Training Hospital 54
Next Page